28This interpretation is, moreover, applied by the Commission in its guidelines on the regulation of medicinal products (published in The rules governing medicinal products in the European Community, Volume 2A: Notice to applicants for marketing authorisations for medicinal products for human use in the Member States of the European Community, Chapter I, point 4.2.2).
Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.